Lancashire Teaching Hospitals NHS Foundation Trust

Running trials

• Recruiting

  A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

  NCT06963827· Phase 3· Takeda· Source

• Not yet recruiting

  The U.K. NorthStar Clinical Network

  NCT06711692· University College, London· Source

• Recruiting

  Chronic Radiation Induced Bowel Toxicity Study

  NCT06640959· The Christie NHS Foundation Trust· Source

• Recruiting

  Enabling Genomic Testing in Cancer of Unknown Primary

  NCT06695494· The Christie NHS Foundation Trust· Source

• Active, not recruiting

  Hydrotherapy in Duchenne Muscular Dystrophy (DMD)

  NCT06445985· Lancashire Teaching Hospitals NHS Foundation Trust· Source

• Recruiting

  Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer

  NCT05329532· Phase 1/2· Scancell Ltd· Source

• Active, not recruiting

  Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC

  NCT04821622· Phase 3· Pfizer· Source

• Recruiting

  Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

  NCT03860883· Melanoma and Skin Cancer Trials Limited· Source

• Active, not recruiting

  SCIB1 and iSCIB1+ in Melanoma Patients Receiving Nivolumab With Ipilimumab or SCIB1 With Pembrolizumab (The SCOPE Study)

  NCT04079166· Phase 2· Scancell Ltd· Source

• Recruiting

  International Registry for Men With Advanced Prostate Cancer (IRONMAN)

  NCT03151629· Prostate Cancer Clinical Trials Consortium· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Prostate cancer2 recruiting
• Childhood cancers1 recruiting
• Duchenne muscular dystrophy1 recruiting
• Head and neck cancer1 recruiting
• IgA nephropathy1 recruiting
• Kidney cancer1 recruiting
• Melanoma1 recruiting
• Ovarian cancer1 recruiting
• Triple-negative breast cancer1 recruiting

Closed trials

• Completed

  Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers

  NCT05483933· Phase 1· Shattuck Labs, Inc.· Source

• Completed

  Virtual Peer-to-peer Support Programme for Carers of MND

  NCT04695210· King's College London· Source

• Recruiting

  Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole

  NCT04965298· Phase 3· Norfolk and Norwich University Hospitals NHS Foundation Trust· Source

• Completed

  CHIEF-PD (CHolinesterase Inhibitor to prEvent Falls in Parkinson's Disease)

  NCT04226248· Phase 3· University of Bristol· Source

• Completed

  Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)

  NCT03040999· Phase 3· Merck Sharp & Dohme LLC· Source